Stalfort John A III

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 45% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Stalfort John A III's trades of Taysha Gene Therapies Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
157.91
Quantity 97,401 -39.3%
Value US$1,381,212
Transaction date
Purchase
Price
114.73
Quantity 72,076 -40.4%
Value US$947,787
Transaction date
Purchase
Price
16.00
Quantity 35,000 +25.5%
Value US$560,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-16 2023-08-16
B Purchase
97,401 -39.3%
157.91
US$1,381,212 		97,401 -39.3% 157.91 US$1,381,212
2023-08-16 2023-08-16
B Purchase
79,186 +30.7%
133.47
US$3,168,672 		79,186 +30.7% 133.47 US$3,168,672
2022-07-05 2022-07-05
B Purchase
72,076 -40.4%
114.73
US$947,787 		72,076 -40.4% 114.73 US$947,787
2021-07-08 2021-07-06
B Purchase
35,000 +25.5%
16.00
US$560,000 		35,000 +25.5% 16.00 US$560,000
2020-08-17 2020-08-14
B Purchase
15,700 +3.5%
6.38
US$100,166 		15,700 +3.5% 6.38 US$100,166
2020-08-17 2020-08-13
B Purchase
15,550 +3.6%
6.45
US$100,298 		15,550 +3.6% 6.45 US$100,298
2019-01-07 2019-01-07
B Purchase
1,200 +0.3%
10.94
US$13,128 		1,200 +0.3% 10.94 US$13,128
2019-01-07 2019-01-07
B Purchase
8,021 +1.9%
10.38
US$83,258 		8,021 +1.9% 10.38 US$83,258